A 52 ‐week multicenter randomized controlled study of the efficacy and safety of add‐on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study)

LUTS: Lower Urinary Tract Symptoms, EarlyView.
Source: LUTS: Lower Urinary Tract Symptoms - Category: Urology & Nephrology Authors: Source Type: research

Related Links:

CONCLUSION: The status of executive function and working memory, as well as the age and severity of the pathological symptoms of lower urinary tract should be taken into account when predicting the risks of rejecting BPH and OAB treatment in elderly patients. PMID: 31560296 [PubMed - as supplied by publisher]
Source: Current Aging Science - Category: Geriatrics Tags: Curr Aging Sci Source Type: research
Condition:   Overactive Bladder Intervention:   Drug: Vibegron Sponsor:   Urovant Sciences GmbH Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
CONCLUSIONS: Our results demonstrate no difference in the etiology of nocturia between black and white males. Accordingly, race should not play a role in the evaluation of patients seeking treatment for nocturia. PMID: 31180307 [PubMed - in process]
Source: Canadian Journal of Urology - Category: Urology & Nephrology Tags: Can J Urol Source Type: research
Condition:   Overactive Bladder Interventions:   Drug: Vibegron;   Drug: Placebo Sponsor:   Urovant Sciences GmbH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avodart | Benign Prostatic Hyperplasia | Overactive Bladder | Overactive Bladder Syndrome | Study | Urology & Nephrology